{"transactions":[{"id":759071,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-05-29T21:02:36.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":1800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock units (\"RSUs\") awarded under the Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date."}],"balance_after":2000960,"source":{"system":"sec-edgar","filing":"0001104659-26-068339","document":"tm2615354-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465926068339/tm2615354-5_4seq1.xml","form_type":"4"}},{"id":1315842,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-01-03T22:36:42.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date."}],"balance_after":200960,"source":{"system":"sec-edgar","filing":"0001104659-25-000895","document":"tm251864-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465925000895/tm251864-10_4seq1.xml","form_type":"4"}},{"id":1394961,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-10-02T12:00:14.000Z","date":"2024-10-01","kind":"purchase","planned":false,"acquired":true,"shares":1836,"price":3.4272,"value":6292.3392,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $3.40 to $3.45, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024."}],"balance_after":80960,"source":{"system":"sec-edgar","filing":"0001104659-24-105215","document":"tm2425378-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924105215/tm2425378-1_4seq1.xml","form_type":"4"}},{"id":1394960,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-10-02T12:00:14.000Z","date":"2024-09-30","kind":"purchase","planned":false,"acquired":true,"shares":22000,"price":0.228,"value":5016.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.2258 to $0.2302, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4."}],"balance_after":1186865,"source":{"system":"sec-edgar","filing":"0001104659-24-105215","document":"tm2425378-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924105215/tm2425378-1_4seq1.xml","form_type":"4"}},{"id":1445508,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-07-31T20:09:00.000Z","date":"2024-05-28","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":0.5183,"value":7774.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 3, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.5161 to $0.5194, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":1164865,"source":{"system":"sec-edgar","filing":"0001104659-24-084344","document":"tm2420560-7_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924084344/tm2420560-7_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-06-03"}},{"id":1445507,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-07-31T20:08:32.000Z","date":"2024-05-22","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":0.64,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 23, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'."}],"balance_after":1149865,"source":{"system":"sec-edgar","filing":"0001104659-24-084343","document":"tm2420560-6_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924084343/tm2420560-6_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-05-23"}},{"id":1445506,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-07-31T20:08:32.000Z","date":"2024-05-21","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":0.579,"value":14475.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 23, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'."}],"balance_after":1124865,"source":{"system":"sec-edgar","filing":"0001104659-24-084343","document":"tm2420560-6_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924084343/tm2420560-6_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-05-23"}},{"id":1445505,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-07-31T20:07:56.000Z","date":"2024-05-13","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.49,"value":4900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 14, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'."}],"balance_after":1099865,"source":{"system":"sec-edgar","filing":"0001104659-24-084341","document":"tm2420560-5_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924084341/tm2420560-5_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-05-14"}},{"id":1445504,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-07-31T20:07:56.000Z","date":"2024-05-11","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.4665,"value":4665.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 14, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'."}],"balance_after":1089865,"source":{"system":"sec-edgar","filing":"0001104659-24-084341","document":"tm2420560-5_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924084341/tm2420560-5_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-05-14"}},{"id":1445503,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-07-31T20:07:56.000Z","date":"2024-05-10","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.465,"value":9300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 14, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'."}],"balance_after":1079865,"source":{"system":"sec-edgar","filing":"0001104659-24-084341","document":"tm2420560-5_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924084341/tm2420560-5_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-05-14"}},{"id":1445502,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-07-31T20:07:31.000Z","date":"2024-05-07","kind":"purchase","planned":false,"acquired":true,"shares":66300,"price":0.3743,"value":24816.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 7, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.3738 to $0.3747, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":1059865,"source":{"system":"sec-edgar","filing":"0001104659-24-084339","document":"tm2420560-4_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924084339/tm2420560-4_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-05-07"}},{"id":1445501,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-07-31T20:06:39.000Z","date":"2024-05-06","kind":"purchase","planned":false,"acquired":true,"shares":135000,"price":0.3753,"value":50665.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 7, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.3498 to $0.399, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":993565,"source":{"system":"sec-edgar","filing":"0001104659-24-084337","document":"tm2420560-3_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924084337/tm2420560-3_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-05-07"}},{"id":1445500,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-07-31T20:06:01.000Z","date":"2024-04-19","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":0.5199,"value":7798.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 25, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'."}],"balance_after":858565,"source":{"system":"sec-edgar","filing":"0001104659-24-084336","document":"tm2420560-2_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924084336/tm2420560-2_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-04-25"}},{"id":1445499,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-07-31T20:05:21.000Z","date":"2024-04-18","kind":"purchase","planned":false,"acquired":true,"shares":115072,"price":0.5255,"value":60470.336,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 19, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.4936 to $0.59, inclusive. The Reporting\nPerson undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of\nsecurities purchased at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":843565,"source":{"system":"sec-edgar","filing":"0001104659-24-084334","document":"tm2420560-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924084334/tm2420560-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-04-19"}},{"id":1445498,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-07-31T20:05:21.000Z","date":"2024-04-17","kind":"purchase","planned":false,"acquired":true,"shares":130000,"price":0.5457,"value":70941.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 19, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.5392 to $0.555, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":728493,"source":{"system":"sec-edgar","filing":"0001104659-24-084334","document":"tm2420560-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924084334/tm2420560-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-04-19"}},{"id":1495469,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-06-03T13:00:47.000Z","date":"2024-05-28","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0.5183,"value":7774.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.5161 to $0.5194, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":1164865,"source":{"system":"sec-edgar","filing":"0001104659-24-067529","document":"tm2416255-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924067529/tm2416255-1_4seq1.xml","form_type":"4"}},{"id":1504030,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-05-23T10:00:11.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0.64,"value":16000.0,"ownership":{"direct":true},"balance_after":1149865,"source":{"system":"sec-edgar","filing":"0001104659-24-064415","document":"tm2415334-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924064415/tm2415334-1_4seq1.xml","form_type":"4"}},{"id":1504029,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-05-23T10:00:11.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0.579,"value":14475.0,"ownership":{"direct":true},"balance_after":1124865,"source":{"system":"sec-edgar","filing":"0001104659-24-064415","document":"tm2415334-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924064415/tm2415334-1_4seq1.xml","form_type":"4"}},{"id":1517834,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-05-14T11:53:11.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0.49,"value":4900.0,"ownership":{"direct":true},"balance_after":1099865,"source":{"system":"sec-edgar","filing":"0001104659-24-060889","document":"tm2414376-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924060889/tm2414376-1_4seq1.xml","form_type":"4"}},{"id":1517833,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-05-14T11:53:11.000Z","date":"2024-05-11","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0.4665,"value":4665.0,"ownership":{"direct":true},"balance_after":1089865,"source":{"system":"sec-edgar","filing":"0001104659-24-060889","document":"tm2414376-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924060889/tm2414376-1_4seq1.xml","form_type":"4"}},{"id":1517832,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-05-14T11:53:11.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0.465,"value":9300.0,"ownership":{"direct":true},"balance_after":1079865,"source":{"system":"sec-edgar","filing":"0001104659-24-060889","document":"tm2414376-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924060889/tm2414376-1_4seq1.xml","form_type":"4"}},{"id":1525021,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-05-07T23:41:40.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":66300,"price":0.3743,"value":24816.09,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.3738 to $0.3747, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":1059865,"source":{"system":"sec-edgar","filing":"0001104659-24-058218","document":"tm2413818-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924058218/tm2413818-1_4seq1.xml","form_type":"4"}},{"id":1525020,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-05-07T13:14:17.000Z","date":"2024-05-06","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0.3753,"value":50665.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.3498 to $0.399, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":993565,"source":{"system":"sec-edgar","filing":"0001104659-24-057784","document":"tm2413699-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924057784/tm2413699-1_4seq1.xml","form_type":"4"}},{"id":1535566,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-04-25T20:01:22.000Z","date":"2024-04-19","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0.5199,"value":7798.5,"ownership":{"direct":true},"balance_after":858565,"source":{"system":"sec-edgar","filing":"0001104659-24-051948","document":"tm2412707d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924051948/tm2412707d1_4seq1.xml","form_type":"4"}},{"id":1538566,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-04-19T10:05:13.000Z","date":"2024-04-18","kind":"grant","planned":false,"acquired":true,"shares":115072,"price":0.5255,"value":60470.336,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.4936 to $0.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":843565,"source":{"system":"sec-edgar","filing":"0001104659-24-049027","document":"tm2412256-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924049027/tm2412256-1_4seq1.xml","form_type":"4"}},{"id":1538565,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-04-19T10:05:13.000Z","date":"2024-04-17","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0.5457,"value":70941.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.5392 to $0.555, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":728493,"source":{"system":"sec-edgar","filing":"0001104659-24-049027","document":"tm2412256-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924049027/tm2412256-1_4seq1.xml","form_type":"4"}},{"id":1579171,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-03-14T00:54:41.000Z","date":"2024-03-11","kind":"grant","planned":false,"acquired":true,"shares":305198,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The grant of restricted stock awards (\"RSAs\") to the Reporting Person as reported herein was approved by the board of directors of the Issuer on March 11, 2024 (\"Grant Date\") as part of the Issuer's grant of equity awards in the ordinary course. The RSAs shall vest in equal yearly installments over the course of two (2) years, with vesting occurring on each of the first and second anniversary of the Grant Date."}],"balance_after":598493,"source":{"system":"sec-edgar","filing":"0001104659-24-034091","document":"tm248822-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924034091/tm248822-1_4seq1.xml","form_type":"4"}},{"id":1815195,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-08-04T20:05:35.000Z","date":"2023-08-02","kind":"grant","planned":false,"acquired":true,"shares":31185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of July 26, 2023, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date."}],"balance_after":293295,"source":{"system":"sec-edgar","filing":"0001104659-23-087819","document":"tm2322868-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465923087819/tm2322868-2_4seq1.xml","form_type":"4"}},{"id":1915040,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Common Stock","published_at":"2023-04-24T10:44:08.000Z","date":"2023-04-20","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares were fully vested upon grant."}],"balance_after":262110,"source":{"system":"sec-edgar","filing":"0001104659-23-048639","document":"tm2313513-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465923048639/tm2313513-2_4seq1.xml","form_type":"4"}},{"id":2068905,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-04T12:35:25.000Z","date":"2022-09-18","kind":"grant","acquired":true,"shares":31185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of July 26, 2022, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date."}],"balance_after":187110,"source":{"system":"sec-edgar","filing":"0001104659-23-000634","document":"tm231419-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465923000634/tm231419-2_4seq1.xml","form_type":"4"}},{"id":2477590,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-11T01:04:41.000Z","date":"2021-12-10","kind":"grant","acquired":true,"shares":31185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of July 26, 2021, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date."}],"balance_after":155925,"source":{"system":"sec-edgar","filing":"0001104659-21-148753","document":"tm2135032-8_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465921148753/tm2135032-8_4.xml","form_type":"4"}},{"id":3072671,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-07-31T21:10:22.000Z","date":"2020-07-26","kind":"grant","acquired":true,"shares":31185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded on July 26, 2020 under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of the date of grant, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date."}],"balance_after":124740,"source":{"system":"sec-edgar","filing":"0001104659-20-089158","document":"tm2025773d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465920089158/tm2025773d1_4.xml","form_type":"4"}},{"id":3455458,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-07-26T21:03:54.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":31185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded on July 26, 2019 under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of the date of grant, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 1,933,794 shares of Common Stock owned by ACCBT Corp. and (ii) 138,806 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares."}],"balance_after":2166155,"source":{"system":"sec-edgar","filing":"0001144204-19-036266","document":"tv525662_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420419036266/tv525662_4.xml","form_type":"4"}},{"id":3860121,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-07-27T20:05:11.000Z","date":"2018-07-26","kind":"grant","acquired":true,"shares":31185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded on July 26, 2018 under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of the date of grant, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 1,933,794 shares of Common Stock owned by ACCBT Corp. and (ii) 138,806 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares."}],"balance_after":2134970,"source":{"system":"sec-edgar","filing":"0001144204-18-040473","document":"tv498316_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420418040473/tv498316_4.xml","form_type":"4"}},{"id":4251237,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2017-07-26T21:29:51.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":41580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option is fully vested exercisable as of the date of grant and shall remain exercisable until the 2nd anniversary of the date of grant."}],"balance_after":41580,"derivative":{"exercise_price":4.81,"exercise_date":"2017-07-26","expiration_date":"2019-07-26","underlying":"Common Stock","underlying_shares":41580},"source":{"system":"sec-edgar","filing":"0001144204-17-038410","document":"v471333_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420417038410/v471333_4.xml","form_type":"4"}},{"id":4251236,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":43252,"kind":"person","name":"Lebovits Chaim","position":1,"cik":"0001406302","reported_name":"Lebovits Chaim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-07-26T21:29:51.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":31185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded on July 26, 2017 under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of the date of grant, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 1,933,794 shares of Common Stock owned by ACCBT Corp. and (ii) 138,806 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares."}],"balance_after":2103785,"source":{"system":"sec-edgar","filing":"0001144204-17-038410","document":"v471333_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420417038410/v471333_4.xml","form_type":"4"}}]}